Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer’s Disease

Amyloid-β (Aβ) accumulation and tauopathy are considered the pathological hallmarks of Alzheimer’s disease (AD), but attenuation in choline signaling, including decreased nicotinic acetylcholine receptors (nAChRs), is evident in the early phase of AD. Currently, there are no drugs that can suppress...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kazuyuki Takata, Hiroyuki Kimura, Daijiro Yanagisawa, Koki Harada, Kaneyasu Nishimura, Yoshihisa Kitamura, Shun Shimohama, Ikuo Tooyama
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2022-04-01
Saila:Molecules
Gaiak:
neurodegenerative disease
nicotinic acetylcholine receptors
glial cells
neuroprotection
neuroinflammation
subtype
Sarrera elektronikoa:https://www.mdpi.com/1420-3049/27/9/2780
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak